Revvity ROA 2010-2024 | RVTY
Current and historical return on assets (ROA) values for Revvity (RVTY) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Revvity ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-09-30 | $0.25B | $12.77B | 1.91% |
| 2024-06-30 | $0.17B | $13.43B | 1.26% |
| 2024-03-31 | $0.15B | $13.43B | 1.10% |
| 2023-12-31 | $0.69B | $13.57B | 4.96% |
| 2023-09-30 | $0.74B | $13.42B | 5.26% |
| 2023-06-30 | $0.82B | $14.22B | 5.76% |
| 2023-03-31 | $0.96B | $14.64B | 6.77% |
| 2022-12-31 | $0.57B | $14.13B | 3.99% |
| 2022-09-30 | $0.63B | $13.82B | 4.36% |
| 2022-06-30 | $0.67B | $14.19B | 4.57% |
| 2022-03-31 | $0.74B | $14.85B | 5.54% |
| 2021-12-31 | $0.94B | $15.00B | 7.96% |
| 2021-09-30 | $1.13B | $14.90B | 11.23% |
| 2021-06-30 | $1.18B | $8.74B | 14.63% |
| 2021-03-31 | $1.07B | $8.76B | 14.20% |
| 2020-12-31 | $0.73B | $7.96B | 10.46% |
| 2020-09-30 | $0.41B | $6.87B | 6.25% |
| 2020-06-30 | $0.30B | $6.64B | 4.53% |
| 2020-03-31 | $0.23B | $6.38B | 3.52% |
| 2019-12-31 | $0.23B | $6.54B | 3.57% |
| 2019-09-30 | $0.23B | $6.49B | 3.75% |
| 2019-06-30 | $0.25B | $6.40B | 4.14% |
| 2019-03-31 | $0.25B | $6.09B | 4.14% |
| 2018-12-31 | $0.24B | $5.98B | 3.98% |
| 2018-09-30 | $0.13B | $5.86B | 2.10% |
| 2018-06-30 | $0.14B | $5.96B | 2.44% |
| 2018-03-31 | $0.28B | $6.13B | 5.19% |
| 2017-12-31 | $0.29B | $6.09B | 5.93% |
| 2017-09-30 | $0.40B | $4.74B | 8.89% |
| 2017-06-30 | $0.37B | $4.61B | 8.35% |
| 2017-03-31 | $0.23B | $4.34B | 5.28% |
| 2016-12-31 | $0.23B | $4.28B | 5.51% |
| 2016-09-30 | $0.24B | $4.31B | 5.62% |
| 2016-06-30 | $0.23B | $4.19B | 5.64% |
| 2016-03-31 | $0.22B | $4.21B | 5.31% |
| 2015-12-31 | $0.21B | $4.17B | 5.20% |
| 2015-09-30 | $0.18B | $4.03B | 4.30% |
| 2015-06-30 | $0.16B | $4.08B | 4.02% |
| 2015-03-31 | $0.16B | $4.03B | 4.08% |
| 2014-12-31 | $0.16B | $4.13B | 3.94% |
| 2014-09-30 | $0.19B | $3.89B | 4.90% |
| 2014-06-30 | $0.19B | $3.94B | 4.86% |
| 2014-03-31 | $0.17B | $3.97B | 4.34% |
| 2013-12-31 | $0.17B | $3.95B | 4.33% |
| 2013-09-30 | $0.08B | $3.85B | 2.19% |
| 2013-06-30 | $0.07B | $3.81B | 1.92% |
| 2013-03-31 | $0.08B | $3.81B | 2.08% |
| 2012-12-31 | $0.07B | $3.90B | 1.84% |
| 2012-09-30 | $0.00B | $3.89B | 0.08% |
| 2012-06-30 | $0.01B | $3.80B | 0.27% |
| 2012-03-31 | $0.01B | $3.86B | 0.16% |
| 2011-12-31 | $0.01B | $3.86B | 0.23% |
| 2011-09-30 | $0.39B | $3.40B | 11.49% |
| 2011-06-30 | $0.36B | $3.60B | 10.90% |
| 2011-03-31 | $0.39B | $3.31B | 12.15% |
| 2010-12-31 | $0.39B | $3.21B | 12.38% |
| 2010-09-30 | $0.13B | $3.25B | 4.20% |
| 2010-06-30 | $0.13B | $3.15B | 4.30% |
| 2010-03-31 | $0.10B | $3.03B | 3.18% |
| 2009-12-31 | $0.08B | $3.06B | 2.78% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.453B | $2.751B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $84.995B | 10.55 |
| Cencora (COR) | United States | $43.734B | 16.44 |
| DiDi Global (DIDIY) | China | $22.941B | 0.00 |
| Natera (NTRA) | United States | $20.871B | 0.00 |
| ICON (ICLR) | Ireland | $16.879B | 15.03 |
| Viatris (VTRS) | United States | $14.478B | 4.46 |
| Avantor (AVTR) | United States | $14.307B | 21.45 |
| BioMerieux (BMXMF) | France | $12.659B | 0.00 |
| CochLear (CHEOY) | Australia | $11.807B | 0.00 |
| Solventum (SOLV) | United States | $11.540B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.417B | 29.35 |
| Doximity (DOCS) | United States | $10.302B | 60.64 |
| Charles River Laboratories (CRL) | United States | $9.314B | 18.00 |
| HealthEquity (HQY) | United States | $8.212B | 41.20 |
| Sonic Healthcare (SKHHY) | Australia | $8.208B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.322B | 29.43 |
| Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
| Sotera Health (SHC) | United States | $3.759B | 20.11 |
| Organon (OGN) | United States | $3.719B | 3.75 |
| BrightSpring Health Services (BTSG) | United States | $2.967B | 63.11 |
| Surgery Partners (SGRY) | United States | $2.493B | 28.42 |
| Concentras Parent (CON) | United States | $2.491B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.291B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.069B | 0.00 |
| Premier (PINC) | United States | $2.067B | 10.76 |
| PACS (PACS) | United States | $1.992B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.969B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.730B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.711B | 44.90 |
| Teladoc Health (TDOC) | United States | $1.544B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.224B | 11.98 |
| Progyny (PGNY) | United States | $1.208B | 24.47 |
| Embecta (EMBC) | United States | $1.161B | 8.12 |
| CareDx (CDNA) | United States | $1.102B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.090B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.874B | 5.91 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Agilon Health (AGL) | United States | $0.775B | 0.00 |
| SBC Medicals (SBC) | United States | $0.649B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.492B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.478B | 0.00 |
| DocGo (DCGO) | United States | $0.444B | 16.73 |
| Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
| Enhabit (EHAB) | United States | $0.387B | 33.48 |
| Sera Prognostics (SERA) | United States | $0.275B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.268B | 0.00 |
| LifeMD (LFMD) | United States | $0.212B | 0.00 |
| Biodesix (BDSX) | United States | $0.198B | 0.00 |
| Beauty Health (SKIN) | United States | $0.176B | 0.00 |
| Nutex Health (NUTX) | United States | $0.160B | 0.00 |
| ModivCare (MODV) | United States | $0.156B | 8.44 |
| MultiPlan (MPLN) | United States | $0.108B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.099B | 0.00 |
| So-Young (SY) | China | $0.093B | 15.69 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| OncoCyte (OCX) | United States | $0.037B | 0.00 |
| NeueHealth (NEUE) | United States | $0.033B | 0.87 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Oncology Institute (TOI) | United States | $0.016B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |